Factor IX A Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMRMOA5271)
◆英語タイトル:Factor IX A Inhibitors -Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMRMOA5271
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Factor IX A Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Factor IX A Inhibitors-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Factor IX A Inhibitors. This report provides information on the therapeutic development based on the Factor IX A Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Factor IX A Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Factor IX A Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Factor IX A Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

*** レポート目次(コンテンツ)***

• Factor IX A Inhibitors Overview
• Factor IX A Inhibitors Disease Associated
• Factor IX A Inhibitors Pipeline Therapeutics
• Factor IX A Inhibitors Therapeutics under Development by Companies
• Factor IX A Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Factor IX A Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Factor IX A Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Factor IX A Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Factor IX A Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Factor IX A Inhibitors – Discontinued Products
• Factor IX A Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Factor IX A Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Factor IX A Inhibitors by Therapy Area, 2015
• Number of Products under Development for Factor IX A Inhibitors, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Factor IX A Inhibitors Assessment by Monotherapy Products
• Factor IX A Inhibitors Assessment by Combination Products
• Factor IX A Inhibitors Assessment by Route of Administration
• Factor IX A Inhibitors Assessment by Stage and Route of Administration
• Factor IX A Inhibitors Assessment by Molecule Type
• Factor IX A Inhibitors Assessment by Stage and Molecule Type
• Factor IX A Inhibitors Therapeutics – Discontinued Products
• Factor IX A Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2015

• Number of Products under Development for Factor IX A Inhibitors by Therapy Area, 2015
• Number of Products under Development for Factor IX A Inhibitors, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Factor IX A Inhibitors Assessment by Monotherapy Products
• Factor IX A Inhibitors Assessment by Combination Products
• Factor IX A Inhibitors Assessment by Route of Administration
• Factor IX A Inhibitors Assessment by Stage and Route of Administration
• Factor IX A Inhibitors Assessment by Molecule Type
• Factor IX A Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • MT-2 Melatonin Receptor Agonists:アゴニストのグローバル市場2015(薬開発、治験動向)
    DelveInsight’s,“MT-2 Melatonin Receptor Agonists-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under MT-2 Melatonin Rece …
  • 局所ドラッグデリバリ(局所薬物送達)の世界市場予測(~2021)
    The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence …
  • 世界の産業用バイオマスボイラー市場2016
    Notes:Production, means the output of Industrial Biomass Boiler Revenue, means the sales value of Industrial Biomass Boiler This report studies Industrial Biomass Boiler in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in glo …
  • コロンビアカード及び決済市場における市場機会
    Colombia is the fourth-largest economy in Latin America. It had a population of 46 million in 2012, of which 15.7 million lived below the poverty line. Colombia has a huge unbanked population with more than 40% of the population not holding a bank account. Low banking penetration presents huge poten …
  • 世界のステンレス流し台市場2016
    Notes:Production, means the output of Stainless Steel Sink Revenue, means the sales value of Stainless Steel Sink This report studies Stainless Steel Sink in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, wit …
  • PetroSA – Mossel Bay LNG Terminal – South Africa:建設プロジェクト概要
    World Market Intelligence's "PetroSA – Mossel Bay LNG Terminal – South Africa - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the PetroSA – Mossel Bay LNG Terminal – South Africa construction project. World Market Intel …
  • 自動車用ヘッドガスケットの世界市場2017-2021:乗用車、商用車
    About Automotive Head Gasket The automotive head gasket is used as a sealant in between the engine block and engine head. It helps to maintain effective combustion in the engine and prevents leakages. The global automotive head gasket market is directly proportional to the automobile production. Esp …
  • ソフトドリンク(飲料)市場(~2017):Mauritania
    Synopsis "Soft Drinks Market in Mauritania: Databook to 2017" is the result of Canadean’s extensive market research covering the Soft Drinks market in Mauritania. The report presents detailed historic and forecast data on the Soft Drinks consumption trends in Mauritania, offering consumption volume …
  • 異文化トレーニングコースの世界市場2017-2021
    About Cross-Cultural TrainingCross-cultural training is used to increase the knowledge and skills of individuals that will help them understand and adjust to new cultures. In the past two decades, globalization and technological advances have changed the dynamics of the education and corporate train …
  • 壁紙市場(規模、動向、予測):日本
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for wallpaper in Japan. The research includes historic market data from 2007 to 2013 and forecasts until 2018 which makes the report an invaluable resource for industry executives, m …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMRMOA5271 )"Factor IX A Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)" (英文:Factor IX A Inhibitors -Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。